All In Biotech

Drug Trial Radar · NCT02519660

Needle Procedures Success Rate After Application of Ralydan vs EMLA in Children

Lidocaine/Tetracaine Patch (Ralydan) vs Lidocaine/Prilocaine Cream (EMLA) for Needle Related Procedures in Children: a Multicenter, Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Mar 28, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 339 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

339

Actual

Start

Apr 2015

Primary completion

Dec 2015

Study completion Dec 2015

Sponsor

Lead sponsor
IRCCS Burlo GarofoloAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 11, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
Who can join
All sexes, from 3 years, up to 10 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Needle-related procedures are among the most common sources of pain and distress for children in the health care setting. More than 50% of children reported pain during these procedures. The necessity for pain management during these procedures is well established. Topical anesthesia has been shown to be effective in managing needle-related pain. Eutectic mixture of local anaesthetic (EMLA) cream is the topical anesthetic most used. The application of this mixture of lidocaine and prilocaine reduce pain during needle procedures in children. To be effective EMLA cream must be applied for at least 60 minutes before needle procedure. This is the major limitation for its use in emergency settings. Ralydan patch is a drug delivery system designed to release local anaesthetics (lidocaine and tetracaine) through the skin. There is evidence of pain relief after 30 minutes from its application. Only one randomized controlled trial compared the two topical anaesthetics in children during venipuncture and showed that Ralydan patch led to superior analgesia than EMLA cream, even if in this study the two anaesthetics were applied only for 35 minutes before needle procedure. No differences were found in success rate of the procedure and vein visibility. In adult patients, Ralydan and EMLA were equally effective in pain relief after 60 minutes from application. To the best of the investigators' knowledge there is no published study that compared needle procedure success rate in children and pain relief effectiveness of lidocaine/tetracaine patch and lidocaine/prilocaine cream, at time of their maximum analgesic effect. The aim of this study is to compare Ralydan patch and EMLA cream at time of their maximum analgesic effect (30 minutes vs 60 minutes), regard to needle procedure success rate at the first attempt and pain relief in children.

Conditions

  • Procedural Pain Relief

Interventions

  • Lidocaine/Tetracaine patchDrug

  • Lidocaine/Prilocaine creamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success at the first attemptTime frame: Intraoperative

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Ospedale Pediatrico Pausilipon - Servizio di terapia del dolore e cure palliative

    Naples, Campania, Italy

  • IRCCS Burlo Garofolo

    Trieste, Friuli Venezia Giulia, Italy

  • Università degli studi di Padova - Centro Regionale Veneto di terapia del dolore e cure palliative pediatriche

    Padova, Veneto, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.